Byetta (exenatide)

DRUG3 trials

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Baylor College of Medicine, Beijing Chao Yang Hospital

Conditions

Coronary Endothelial FunctionObesityType 2 DiabetesWeight Loss

Phase 3

The Effects of Exenatide (Byetta ) on Energy Expenditure and Weight Loss in Nondiabetic Obese Subjects

CompletedNCT00856609

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Obesity, Weight Loss

Start: 2009-03-03End: 2016-09-19Updated: 2019-06-04

Phase 4

The Effect of Byetta and Symlin on Post-meal Meal Blood Sugar Levels in Children With Type 2 Diabetes

CompletedNCT00950677

Baylor College of MedicineType 2 Diabetes

Start: 2009-07-31End: 2011-05-31Updated: 2017-04-24

Evaluate the Effect of Exenatide Treatment on Coronary Artery Endothelial Function

Beijing Chao Yang HospitalCoronary Endothelial Function

Start: 2015-11-30End: 2018-01-31Target: 100Updated: 2015-10-22